Articles

Workers should replace 80% of their income for each year of retirement, new research suggests

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and Zepbound maker Eli Lilly a lift.

Goldman Sachs reported revenue drops in two of its three main business lines, but trading revenue was enough to satisfy investors.

Central banks rarely announce their interventions in currency markets — but one survey suggests they are very active despite pressure to keep out.

“If he had moved my money out of the market weeks ago, much of my loss could have been prevented.”

The U.S. is not the trade titan that Trump believes it is.

Looking at the demand for put over call options, fear remains at extreme levels despite the 90-day delay in most tariffs, say strategists led by John Marshall, head of derivatives research at Goldman Sachs.

Strong U.S. production isn’t just good economic policy; it’s about national security and public health.

“After what quickly became a heated discussion, the agent advised me that canceling the policy would end any chance of a payout.”

Citigroup downgrades U.S. stocks to neutral, saying valuations are still too rich.

At the heart of his property portfolio is Xanadu 2.0, an expansive compound named for the fictional estate in the movie ‘Citizen Kane.’

A surprising new collection of potential housing hot spots— and many are in relatively affordable ZIP Codes.